Bio-Rad Laboratories, Inc. (BIO): Shareholders' Equity
$7.45B
As of 2025-12-31
$7.17B
As of 2026-06-30
-8.1%
3-year compound annual growth
-5.5%
5-year compound annual growth
+11.6%
10-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $7.45B | +13.5% | 2026-02-13, Balance as of period end |
| 2024-12-31 | $6.57B | -24.8% | 2026-02-13, Balance as of period end |
| 2023-12-31 | $8.74B | -9.1% | 2026-02-13, Balance as of period end |
| 2022-12-31 | $9.62B | -29.7% | 2025-02-14, Balance as of period end |
| 2021-12-31 | $13.69B | +38.4% | 2024-02-16, Balance as of period end |
| 2020-12-31 | $9.89B | +71.8% | 2023-02-17, Balance as of period end |
| 2019-12-31 | $5.76B | +43.1% | 2022-02-11, Balance as of period end |
| 2018-12-31 | $4.02B | +37.2% | 2021-02-16, Balance as of period end |
| 2017-12-31 | $2.93B | +13.6% | 2020-03-02, Balance as of period end |
| 2016-12-31 | $2.58B | +3.8% | 2019-04-01, Balance as of period end |
| 2015-12-31 | $2.49B | +13.7% | 2018-04-16, Balance as of period end |
| 2014-12-31 | $2.19B | -0.1% | 2017-03-01, Balance as of period end |
| 2013-12-31 | $2.19B | +8.5% | 2015-03-02, Balance as of period end |
| 2012-12-31 | $2.02B | +15.5% | 2014-03-18, Balance as of period end |
| 2011-12-31 | $1.74B | +13.5% | 2013-03-18, Balance as of period end |
| 2010-12-31 | $1.54B | +22.0% | 2012-02-29, Balance as of period end |
| 2009-12-31 | $1.26B | n/a | 2011-02-28, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Bio-Rad Laboratories, Inc. (BIO) | 2025-12-31 | $7.45B | +13.5% |
| Revvity, Inc. (RVTY) | 2025-12-28 | $7.25B | -5.4% |
| Waters Corp (WAT) | 2025-12-31 | $2.56B | +40.1% |
| Bruker Corp (BRKR) | 2025-12-31 | $2.47B | +37.6% |
| Mettler Toledo International Inc (MTD) | 2025-12-31 | -$23.64M | n/m |
| Illumina, Inc. (ILMN) | 2025-12-28 | $2.72B | +14.7% |
| Avantor, Inc. (AVTR) | 2025-12-31 | $5.57B | -6.6% |
| Agilent Technologies, Inc. (A) | 2025-10-31 | $6.74B | +14.3% |
| 10x Genomics, Inc. (TXG) | 2025-12-31 | $796.33M | +12.1% |
Compare BIO, RVTY, WAT, BRKR side by side · Screen every company in Laboratory Analytical Instruments ↗